These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11223957)

  • 1. The use of particle beam mass spectrometry for the measurement of impurities in a nabumetone drug substance, not easily amenable to atmospheric pressure ionisation techniques.
    Wolff JC; Hawtin PN; Monté S; Balogh M; Jones T
    Rapid Commun Mass Spectrom; 2001; 15(4):265-72. PubMed ID: 11223957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfur-specific detection of impurities in cimetidine drug substance using liquid chromatography coupled to high resolution inductively coupled plasma mass spectrometry and electrospray mass spectrometry.
    Evans EH; Wolff JC; Eckers C
    Anal Chem; 2001 Oct; 73(19):4722-8. PubMed ID: 11605853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of gas chromatography/atmospheric pressure chemical ionisation time-of-flight mass spectrometry to impurity identification in Pharmaceutical Development.
    Bristow T; Harrison M; Sims M
    Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1673-81. PubMed ID: 20486265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of pentafluorophenyl hydrazine derivatives to the analysis of nabumetone and testosterone in human plasma by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
    Sheen JF; Her GR
    Anal Bioanal Chem; 2004 Dec; 380(7-8):891-7. PubMed ID: 15700167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS characterization of trace impurities contained in calcium folinate.
    Francese G; Corana F; Meneghetti O; Marazza F
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent studies on the electrospray ionisation mass spectrometric behaviour of selected nitrogen-containing drug molecules and its application to drug analysis using liquid chromatography-electrospray ionisation mass spectrometry.
    Smyth WF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):1-20. PubMed ID: 16095984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatography analysis of anti-inflammatory pharmaceuticals with ultraviolet and electrospray-mass spectrometry detection in suspected counterfeit homeopathic medicinal products.
    Panusa A; Multari G; Incarnato G; Gagliardi L
    J Pharm Biomed Anal; 2007 Mar; 43(4):1221-7. PubMed ID: 17127029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of impurities in vertilmicin sulfate by liquid chromatography ion-trap mass spectrometry.
    Yuan YZ; Zhang M; Fan XL; Hu CQ; Jin SH; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Jun; 80():1-8. PubMed ID: 23518304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
    Vuletić M; Cindrić M; Koruznjak JD
    J Pharm Biomed Anal; 2005 Apr; 37(4):715-21. PubMed ID: 15797793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of electrospray ionisation, atmospheric pressure chemical ionisation and atmospheric pressure photoionisation for the identification of metabolites from labile artemisinin-based anti-malarial drugs using a QTRAP® mass spectrometer.
    Louw S; Njoroge M; Chigorimbo-Murefu N; Chibale K
    Rapid Commun Mass Spectrom; 2012 Oct; 26(20):2431-42. PubMed ID: 22976210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between liquid chromatography-UV detection and liquid chromatography-mass spectrometry for the characterization of impurities and/or degradants present in trimethoprim tablets.
    Barbarin N; Henion JD; Wu Y
    J Chromatogr A; 2002 Sep; 970(1-2):141-54. PubMed ID: 12350089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for identification of leachables in packaged pharmaceutical liquid formulations.
    Pan C; Harmon F; Toscano K; Liu F; Vivilecchia R
    J Pharm Biomed Anal; 2008 Feb; 46(3):520-7. PubMed ID: 18180126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography-tandem mass spectrometry for the identification of impurities in d-allethrin samples.
    Fiori J; Bragieri M; Zanotti MC; Liverani A; Borzatta V; Mancini F; Cavrini V; Andrisano V
    J Chromatogr A; 2005 Dec; 1099(1-2):149-56. PubMed ID: 16188264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biotransformation and disposition studies of nabumetone in humans and minipigs using high-performance liquid chromatography with ultraviolet, fluorescence and mass spectrometric detection.
    Nobilis M; Kopecký J; Kvetina J; Svoboda Z; Pour M; Kunes J; Holcapek M; Kolárová L
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):641-56. PubMed ID: 12899954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the components of bitespiramycin by liquid chromatography-mass spectrometry.
    Wang MJ; Xue J; Zou WB; Wang Y; Hu CQ; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2012 Jul; 66():402-10. PubMed ID: 22482901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillary liquid chromatography/atmospheric-pressure matrix-assisted laser desorption/ionisation ion trap mass spectrometry: a comparison with liquid chromatography/matrix-assisted laser desorption/ionisation time-of-flight and liquid chromatography/electrospray ionisation quadrupole time-of-flight for the identification of tryptic peptides.
    Creaser CS; Green PS; Kilby PM; Ratcliffe L
    Rapid Commun Mass Spectrom; 2006; 20(5):829-36. PubMed ID: 16470569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.